spantide II
(AZZJAARMZMEIHY-BBKUSFMUSA-N)
Structure
- SMILES
- CCCC[C@@H](C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cccnc1)N)C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCNC(=O)c1cccnc1)N)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc(c(c1)Cl)Cl)N)CC(=O)N)Cc1ccccc1)CC(C)C
- Molecular Formula:
- C86H104Cl2N18O13
- Molecular Weight:
- 1668.760
- Log P:
- 10.1391
- Hydrogen Bond Acceptor:
- 29
- Hydrogen Bond Donor:
- 13
- TPSA:
- 477.28
- CAS Number(s):
- N/A
Synonym(s)
1.
spantide II
2.
1-NicLys-3-(3-Pal)-5-Cl2Phe-6-Asn-7,9-Trp-11-Nle-substance P
3.
1-nicotinyl-lysyl-3-pyridyl-alanyl-5-dichloro-phenylalanyl-6-asparaginyl-7,9-tryptophyl-11-norleucine-substance P
4.
NPCATN-SP
5.
substance P, Nic-Lys(1)-3-Pal(3)-Cl2-Phe(5)-Asn(6)-Trp(7,9)-Nle(11)-
6.
substance P, nicotinyllysyl(1)-3-pyridylalanyl(3)-dichlorophenyl(5)-asparaginyl(6)-tryptophyl(7,9)-norleucine-
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hyperalgesia | 15265675 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.